Correlation Between Histogen and Lixte Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Histogen and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Histogen and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and Lixte Biotechnology.

Diversification Opportunities for Histogen and Lixte Biotechnology

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Histogen and Lixte is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Histogen i.e., Histogen and Lixte Biotechnology go up and down completely randomly.

Pair Corralation between Histogen and Lixte Biotechnology

Given the investment horizon of 90 days Histogen is expected to under-perform the Lixte Biotechnology. In addition to that, Histogen is 2.82 times more volatile than Lixte Biotechnology Holdings. It trades about -0.3 of its total potential returns per unit of risk. Lixte Biotechnology Holdings is currently generating about 0.06 per unit of volatility. If you would invest  208.00  in Lixte Biotechnology Holdings on August 30, 2024 and sell it today you would earn a total of  9.00  from holding Lixte Biotechnology Holdings or generate 4.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Histogen  vs.  Lixte Biotechnology Holdings

 Performance 
       Timeline  
Histogen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Lixte Biotechnology 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Lixte Biotechnology Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Lixte Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Histogen and Lixte Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Histogen and Lixte Biotechnology

The main advantage of trading using opposite Histogen and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.
The idea behind Histogen and Lixte Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years